Status:
RECRUITING
The "New" Place of LEVETIRACETAM in the Management of Status Epilepticus in Children
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Epilepsy in Children
Eligibility:
All Genders
3-17 years
Brief Summary
Status epilepticus is the leading neurological emergency in children, with mortality 2-7% and significant morbidity (10-20%). It is defined as the occurrence of a crisis lasting more than 5 minutes an...
Eligibility Criteria
Inclusion
- Minor patient aged 3 months to 17 years
- 2nd line treatment with LEVETIRACETAM or PHENYTOIN after failure of benzodiazepines
- Supported in one of the participating centers during the period from November 1, 2019 to May 31, 2023
- Subject or parents who have not expressed, after information, their opposition to the reuse of their data for the purposes of this research.
Exclusion
- Patient or parents having expressed their opposition to participating in the study.
Key Trial Info
Start Date :
November 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 16 2025
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT06498362
Start Date
November 16 2023
End Date
May 16 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France, 67091